cancer anorexia market

Anorexia is the loss of the desire to eat, whereas cachexia results from the skeletal muscle mass in excess because of the weight loss. The reason for Anorexia can be Cancer, AIDS, a mental disorder (i.e., Anorexia nervosa), or other diseases. However, during the management of cancer in patients, Anorexia is often neglected.

Cancer anorexia, also referred to as cancer-associated anorexia, is a common and distressing symptom in individuals diagnosed with cancer. It is characterized by a persistent loss of appetite or desire to eat, often leading to significant weight loss, malnutrition, and a decline in overall health. Unlike simple appetite loss due to temporary illness or stress, cancer anorexia is often chronic and multifactorial, contributing significantly to cancer-related morbidity.

Gain insights into the Cancer Anorexia market, epidemiology and treatment landscape. Keep yourself abreast of the recent happenings, major pharma players, key collaborations, and breakthroughs in the domain.

Fill up a simple form to your right and know more about the ongoing R&D, and a lot more about the disease, underlying causes, treatment options, and unmet needs in the Cancer Anorexia market.

Subscribe to DelveInsight's mailing list and never miss an update on pharmaceutical and healthcare industry.

Keep in touch.

Map the recent updates on Cancer Anorexia Treatment Landscape through our latest blog